<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="59882">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02326402</url>
  </required_header>
  <id_info>
    <org_study_id>THEME</org_study_id>
    <nct_id>NCT02326402</nct_id>
  </id_info>
  <brief_title>TandemHeart Experiences and MEthods (THEME Registry)</brief_title>
  <acronym>THEME</acronym>
  <official_title>THEME Registry: TandemHeart Experiences and MEthods (THEME Registry)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CardiacAssist, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>CardiacAssist, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is intended to be a multicenter, prospective observation registry. By collecting
      prospective descriptive data, provide insight into disease defining characteristics
      resulting in the clinical decision to use TandemHeart for mechanical support and enhance
      knowledge of best practice regarding clinical management, weaning and removal/exit
      strategies.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The TandemHeart percutaneous extracorporeal ventricular assist system is used to support
      circulation. The percutaneous cannulas facilitate access to the venous and arterial
      circulatory vessels. When connected to the TandemHeart centrifugal pump, mechanical support
      is provided with sufficient cardiac power to perfuse the organs of the body.

      It is anticipated that THEME Registry analysis will provide insight into disease defining
      characteristics resulting in the clinical decision to use TandemHeart for mechanical support
      and enhance knowledge of best practice regarding clinical management, weaning and removal.
      The progression of the illness prior to, during and following TandemHeart support will be
      collected. The THEME Registry will collect descriptive data regarding patient selection
      criteria and the clinical management of the TandemHeart patient including strategies used to
      wean and remove the TandemHeart. Specifically the objectives of the THEME registry are:

        -  Summarize the characteristics of the patients who receive TandemHeart for temporary
           percutaneous mechanical support with or without an oxygenator, including demographics,
           pre-implant medical history, details of present illness, TandemHeart exit strategy.

        -  Evaluate the timing of initiation of TandemHeart mechanical support in relation to the
           progression of the presenting illness and the association of this with clinical
           outcomes.

        -  Collect descriptive data related to clinical management of the patient while on
           TandemHeart mechanical support, including procedural details, duration of support,
           anticoagulation, hemodynamics and biochemical parameters to define trends in clinical
           care and the association of this decision-making with clinical outcomes.

        -  Collect hospital discharge information including Intensive Care Unit (ICU) and Hospital
           length of stay (LOS).

        -  Collect survival and exit strategy status at 30 and 180 days post-initial TandemHeart
           insertion.

        -  Collect serious adverse events from the time of TandemHeart insertion through removal
           of the TandemHeart System (or TandemHeart Blood Pump).

        -  Provide data regarding TandemHeart case mix, patient characteristics, and outcomes.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2014</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Survival to TandemHeart removal with myocardial recovery, durable ventricular assist device (VAD) implant or transition to another mechanical support device, or cardiac transplant</measure>
    <time_frame>180 Days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Occurrence of Serious Adverse Events (SAEs) related to the TandemHeart System while on TandemHeart support</measure>
    <time_frame>Approximately 72 hours after start of support</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Heart Diseases</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TandemHeart System</intervention_name>
    <description>Percutaneous insertion of TandemHeart System</description>
    <other_name>TandemHeart</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Consented patients in whom the TandemHeart has been inserted percutaneously (e.g. in the
        cath lab or peri-operatively) for any diagnosis/condition at an institution participating
        in the THEME Registry (or transferred to an institution participating in the THEME
        Registry following insertion).
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patient has had the TandemHeart System inserted percutaneously (e.g. in the cath lab
             or peri-operatively)

          2. Age &gt; 18

          3. Patient (or legally authorized representative [LAR]) has signed informed consent

        Exclusion Criteria:

          1. Patient is incarcerated (prisoner)

          2. Participation in a clinical trial of an investigational drug or device
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Howard A Cohen, MD</last_name>
    <role>Study Director</role>
    <affiliation>CardiacAssist, Inc.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christine A Hoyer, RN</last_name>
    <phone>412-963-7770</phone>
    <phone_ext>229</phone_ext>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kristie A Burgess, PhD</last_name>
    <phone>412-963-7770</phone>
    <phone_ext>223</phone_ext>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Banner - University Medical Center Tucson</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85724</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kitsie Johnson</last_name>
      <phone>520-621-0122</phone>
      <email>kjohnson@surgery.arizona.edu</email>
    </contact>
    <investigator>
      <last_name>Zain Khalpey, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California, San Diego</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92037</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melanee Schimmel, BSN, RN</last_name>
      <phone>858-657-5374</phone>
      <email>mschimmel@ucsd.edu</email>
    </contact>
    <investigator>
      <last_name>Eric Adler, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cedars-Sinai Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Hajj, BSN, RN</last_name>
      <phone>310-423-2634</phone>
      <email>jennifer.hajj@cshs.org</email>
    </contact>
    <investigator>
      <last_name>Danny Ramzy, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Michigan Health System</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gretchen Bautista</last_name>
      <phone>734-232-4319</phone>
      <email>genvalen@med.umich.edu</email>
    </contact>
    <contact_backup>
      <last_name>Wendy Warshal</last_name>
      <email>warshal@med.umich.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Stanley Chetcuti, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Henry Ford Hospital</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Margaret Fox, RN, BSN</last_name>
      <phone>313-916-1879</phone>
      <email>mfox2@hfhs.org</email>
    </contact>
    <investigator>
      <last_name>Khaldoon Alaswad, MD,FACC</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic Hospital, Saint Marys Campus</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary Timmons</last_name>
      <phone>507-255-8772</phone>
      <email>timmons.mary@mayo.edu</email>
    </contact>
    <investigator>
      <last_name>David L Joyce, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Temple University Hospital</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19140</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennie Wong, RN, CCRP</last_name>
      <phone>215-707-5340</phone>
      <email>Jennie.Wong@tuhs.temple.edu</email>
    </contact>
    <contact_backup>
      <last_name>Jessica Vazquez, RN</last_name>
      <phone>215-707-3460</phone>
      <email>jessica.vazquez@tuhs.temple.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Brian O'Neill, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh Medical Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurie Dennis, RN</last_name>
      <phone>412-647-6210</phone>
      <email>papugall@upmc.edu</email>
    </contact>
    <investigator>
      <last_name>Catalin Toma, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Baylor College of Medicine</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>University of Virginia Health System</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22908</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shelly Brunk, RN, CCRC</last_name>
      <phone>434-982-1058</phone>
      <email>slb4p@virginia.edu</email>
    </contact>
    <investigator>
      <last_name>Michael Ragosta, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Providence Sacred Heart Medical Center &amp; Children's Hospital</name>
      <address>
        <city>Spokane</city>
        <state>Washington</state>
        <zip>99204</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Passey, RN,BSN,CCRA</last_name>
      <phone>509-474-2041</phone>
      <email>Lisa.Passey@providence.org</email>
    </contact>
    <contact_backup>
      <last_name>Suzanne Anders, ARNP, CCRC</last_name>
      <phone>509-474-4906</phone>
      <email>Suzanne.Anders@providence.org</email>
    </contact_backup>
    <investigator>
      <last_name>Andrew T Coletti, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <lastchanged_date>March 31, 2017</lastchanged_date>
  <firstreceived_date>December 15, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Circulatory support</keyword>
  <keyword>Extracorporeal circulatory support</keyword>
  <keyword>Extracorporeal bypass</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Heart Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
